AI assistant
Sending…
CME GROUP INC. — Director's Dealing 2019
Mar 18, 2019
29871_dirs_2019-03-18_35447fff-3e0c-4323-8b4e-7065901ae715.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2019-03-14
Reporting Person: CRONIN KATHLEEN M (Sr MD Gen Counsel & Corp Secr)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-14 | Common Stock Class A | M | 1319 | $54.3 | Acquired | 41604 | Direct |
| 2019-03-14 | Common Stock Class A | S | 1319 | $168.0 | Disposed | 40285 | Direct |
| 2019-03-14 | Common Stock Class A | M | 7021 | $54.3 | Acquired | 47306 | Direct |
| 2019-03-14 | Common Stock Class A | S | 7021 | $167.4547 | Disposed | 40285 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-14 | Non-Qualified Stock Option (right to buy) | $54.3 | M | 1319 | Disposed | 2020-09-15 | Common Stock Class A (1319) | Direct |
| 2019-03-14 | Non-Qualified Stock Option (right to buy) | $54.3 | M | 7021 | Disposed | 2020-09-15 | Common Stock Class A (7021) | Direct |
Footnotes
F1: On March 14, 2019, Ms. Cronin sold a total of 7,021 shares of CME Group Class A common stock at an average price of $167.45 per share, including the exercise of options. The price ranges were $167.45 through $167.49. The Company maintains a record of the transactions and copies will be provided upon request.
F2: As of 9/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option.
More from CME GROUP INC.
Proxy Solicitation & Information Statement
2026
May 19
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Annual Report
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17